Ks logo

News & Insights

Subscribe
Icon search Icon close

  • People
  • OfficesIcon submenu
    • Icon submenu back back
    • Offices
    • North AmericaIcon submenu
      • Icon submenu back back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Houston
      • Los Angeles
      • New York
      • Northern Virginia
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle EastIcon submenu
      • Icon submenu back back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Moscow
      • Paris
      • Riyadh
    • AsiaIcon submenu
      • Icon submenu back back
      • Asia
      • Singapore
      • Tokyo
  • CapabilitiesIcon submenu
    • Icon submenu back back
    • Capabilities
    • Corporate, Finance and InvestmentsIcon submenu
      • Icon submenu back back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Leveraged Finance
      • Mergers and Acquisitions
      • Middle East and Islamic Finance and Investment
      • Private Credit & Special Situations Investing
      • Private Equity
      • Real Estate
      • Securitization
      • Tax
      • Technology Transactions
    • Government MattersIcon submenu
      • Icon submenu back back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global DisputesIcon submenu
      • Icon submenu back back
      • Trial and Global Disputes
      • Overview
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Insurance Coverage and Recovery
      • Intellectual Property, Patent, Trademark and Copyright Litigation
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / IssuesIcon submenu
      • Icon submenu back back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy
      • Financial Services
      • Food and Beverage
      • Franchise and Hospitality
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • #MeToo
      • COVID-19 Vaccine Rollout
      • Coronavirus
      • Crisis Practice
      • Focus on Women's Health
      • The New Administration: Enforcement and Legislative Impact
  • CareersIcon submenu
    • Icon submenu back back
    • Careers
    • LawyersIcon submenu
      • Icon submenu back back
      • Lawyers
      • Experienced Lawyers
    • StudentsIcon submenu
      • Icon submenu back back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial ClerksIcon submenu
      • Icon submenu back back
      • Judicial Clerks
      • Judicial Clerks
    • Other ProfessionalsIcon submenu
      • Icon submenu back back
      • Other Professionals
      • Other Professionals
  • News & InsightsIcon submenu
    • Icon submenu back back
    • News & Insights
    • NewsIcon submenu
      • Icon submenu back back
      • News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • EventsIcon submenu
      • Icon submenu back back
      • Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • InsightsIcon submenu
      • Icon submenu back back
      • Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • COVID-19 Vaccine Updates
      • China Subsidy Exchange
      • Energy Law Exchange
  • AboutIcon submenu
    • Icon submenu back back
    • About
    • Our FirmIcon submenu
      • Icon submenu back back
      • Our Firm
      • History
      • Our Values
    • DiversityIcon submenu
      • Icon submenu back back
      • Diversity
      • Overview
      • Women’s Initiatives
      • Racial Diversity
      • LBGTQ+ Affinity
    • CitizenshipIcon submenu
      • Icon submenu back back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • NewsIcon submenu
    • Icon submenu back back
    • News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • EventsIcon submenu
    • Icon submenu back back
    • Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • InsightsIcon submenu
    • Icon submenu back back
    • Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • COVID-19 Vaccine Updates
    • China Subsidy Exchange
    • Energy Law Exchange
< Back to Bio
Icon close orange Beverly H. Lorell, M.D.
Calendar view

Event 18 results

Webinar

March 16, 2021
The New Intensified Scrutiny and Enforcement of FDA-Regulated Clinical Trials

Webinar

November 10, 2020
13th Annual King & Spalding Medical Device Summit

Webinar

April 3, 2020
Clinical Trials During the COVID-19 Pandemic and Recent Court Decision on ClinicalTrials.gov

Webinar

May 16, 2019
Just Around the Corner: FDA’s Proposed Rule Would Make Major Changes in Requirements for U.S. Mammography Facilities

Conference

November 13, 2018
11th Annual King & Spalding Pharmaceutical University

Webinar

October 30, 2018
Ouch! Navigating Payment for Research-Related Injuries – How to Avoid the Potholes on the Road to Recovery

Webinar

May 31, 2017
ClinicalTrials.gov – Navigating the New Rule and the Expansion of Public Disclosure of Your Clinical Trial Data

Conference

January 12, 2017
An Introduction to the 21st Century Cures Act

Conference

November 15, 2016
9th Annual King & Spalding Pharmaceutical University

Conference

September 8, 2016
The Conundrum of Medicinal Marijuana: Implications for Healthcare Providers and Pharmaceutical Companies

Conference

July 20, 2016
The New FDA Approach for Expanded Access to Investigational Drugs

Conference

January 20, 2016
The New Era of Informed Consent, including Biospecimens and Privacy

© 2021 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • Client Extranet
  • K&S Alumni Group